Diabetes drug metformin's primary effect is in the gut, not the bloodstream

New study in Diabetes Care suggests new delayed-release metformin could help 40 percent of type 2 diabetes patients that currently can't take metformin.

2015-08-18

(Press-News.org) CHAPEL HILL NC - Although metformin was introduced as a treatment for type 2 diabetes nearly 60 years ago and is now the recommended first-line treatment for newly diagnosed patients, researchers still debate precisely how the drug works. Now, a study published online today in Diabetes Care by researchers at the University of North Carolina School of Medicine, Elcelyx Therapeutics, and other leading endocrinologists provides strong evidence that metformin's primary effect occurs in the gut, not the bloodstream. The paper outlines results from phase 1 and phase 2 studies involving the investigational drug Metformin Delayed Release (Metformin DR), which is designed to target the lower bowel and limit absorption into the blood. "Our clinical trials show that metformin works largely in the lower intestine, reversing half a century of conventional thinking," said John Buse, MD, PhD, first author of the paper, professor of medicine, and director of the Diabetes Care Center at the University of North Carolina School of Medicine. "These findings create an opportunity to develop a new metformin treatment option for the 40 percent of patients that currently can't take this first-line drug of choice." Buse added, "One of the top reasons metformin isn't used for all people with type 2 diabetes is that patients with impaired kidneys accumulate too much drug in the blood, and this can result in life-threatening lactic acidosis. These studies provide evidence that delivering Metformin DR to the lower bowel significantly reduces the amount of metformin in the blood, while maintaining its glucose-lowering effect." Because of this, Metformin DR may prove to be a treatment option for the four million type 2 diabetes patients in the United States with impaired kidney function. In the phase 1 study, single daily doses of Metformin DR were compared to immediate-release metformin (Metformin IR) and extended-release metformin (Metformin XR) in healthy volunteers. The amount of metformin in the bloodstream after Metformin DR treatment was approximately half the amount seen with Metformin IR or Metformin XR. The phase 1 randomized study involved 20 healthy subjects. In the phase 2 study, various doses of Metformin DR were compared to placebo or Metformin XR in patients with type 2 diabetes. Metformin DR exhibited a 40 percent increase in apparent potency compared to Metformin XR. Also, Metformin DR exhibited statistically significant and sustained reductions in fasting plasma glucose levels over 12 weeks compared to placebo. Treatment was generally well tolerated, with adverse events consistent with those for currently available metformin products. The phase 2 randomized trial included 240 patients with type 2 diabetes at multiple study centers. Patients received either 600, 800 or 1,000 mg of Metformin DR once daily, blinded placebo, or unblinded Metformin XR at 1,000 or 2,000 mg per day. Patients previously on metformin (88 percent of subjects) had their metformin therapy withheld for two weeks prior to randomization.

INFORMATION:

The published paper is titled "The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation. Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies," and is available at http://care.diabetesjournals.org/content/early/recent. The results of these studies were previously presented at meetings of the American Diabetes Association and the European Association for the Study of Diabetes. Metformin DR was designed based on Elcelyx's Gut Sensory Modulation (GSM) technology, predicated on the knowledge that enteroendocrine cells - including the L-cell located in the lining of the lower gut - can be modulated locally to elicit systemic physiological and pharmacological effects. This discovery affords a potentially safer platform for developing novel therapies and redesigning existing therapies to meet serious unmet medical needs. John Buse, MD, PhD, was an advisor on the Metformin DR clinical program. He is chief of the division of endocrinology at UNC Health Care, Director of the North Carolina Translational and Clinical Sciences (NC TraCS) Institute (home of the NIH Clinical and Translational Science Awards at UNC), and the Executive Associate Dean for Clinical Research at UNC School of Medicine. END

ELSE PRESS RELEASES FROM THIS DATE:

Accuracy of sexual assault testimonies not affected by alcohol intoxication, study finds

2015-08-18

Research suggests intoxicated victims of sexual assault could accurately retain information from events Findings are being applied to develop National Guidelines for how the police could interview sexual assault victims who were intoxicated during the crime Challenges misconception that intoxicated victims and witnesses are unreliable People are often concerned about the accuracy of testimony given by victims who were intoxicated during a sexual assault- but a new study by University of Leicester researchers has found that while alcohol intoxicated participants ...

Foresight food security: From hunger and poverty to food system approach

2015-08-18

Long considered in relation to malnutrition and humanitarian aid, food security policy should be moving towards a much broader landscape and focusing on regular access to food for a population nearing nine billion towards 2030-2050, while addressing food insecurity for a fraction of communities, according to a JRC foresight report. Due to a growing population, climate change, limiting expansion of agricultural land and increasing demand of high-energy food input, achieving global food security will be one of the most critical challenges in the coming years. Traditionally ...

Linking molecules to microbes

2015-08-18

This news release is available in German. Microbes are the oldest and most successful organisms on the planet, and they communicate and interact using chemistry as their language. While research of the past decades has uncovered fascinating insights into the chemical interactions of microorganisms in the laboratory, it remains extremely challenging to understand what happens in the natural environment. One of the key issues is the difficulty to tie the production of particular molecules to individual bacterial cells or at least populations of cells in complex environmental ...

High-precision control of nanoparticles for digital applications

2015-08-18

For the first time ever, researchers have succeeded in creating arrangements of colloids - tiny particles suspended in a solution - and, importantly, they have managed to control their motion with high precision and speed. Thanks to this new technique developed by scientists at the University of Zurich, colloidal nanoparticles may play a role in digital technologies of the future. Nanoparticles can be rapidly displaced, require little energy and their small footprint offers large storage capacity - all these attributes make them well suited to new data storage applications ...

Johns Hopkins researchers sound off on the dangers of hospital consolidation

2015-08-18

In a commentary published in the Aug. 13 issue of JAMA, Johns Hopkins experts say consolidation of hospitals into massive chains threatens healthy competition, reduces patient choice and could drive up medical expenses. The authors call on the Federal Trade Commission -- the regulatory body overseeing business practices and consumer protection -- to be more vigilant and cautious when hospital systems seek approval to consolidate and to pay particular attention to geographic regions where proposed mergers could create a single dominant hospital system. "It's really Economics ...

Mothers give more than they receive when family struck by major illness

2015-08-18

AMES, Iowa - Mothers are often the caregiver when a child is sick, and that motherly instinct doesn't go away when the child is an adult. In fact, mothers provide more support to adult children with a serious health condition than to their other children, according to new research that will be presented at the American Sociological Association 2015 Annual Meeting. It's a situation that can put older mothers in a vulnerable position, said Megan Gilligan, lead author and assistant professor of human development and family studies at Iowa State University. Gilligan and ...

Proof-of-concept study shows potential for ultrasound to detect signs of preterm labor

2015-08-18

Researchers from North Carolina State University, Institut Langevin and Paris-Descartes University have conducted a proof-of-concept study that raises the possibility of using ultrasound techniques to detect cervical stiffness changes that indicate an increased risk of preterm labor in pregnant women. While additional work needs to be done, it may ultimately give doctors a new tool for determining when to provide treatment that can prevent preterm birth. Premature births can mean low birthweights and other medical problems for newborns, but there are steps that doctors ...

Examining the fate of Fukushima contaminants

2015-08-18

An international research team reports results of a three-year study of sediment samples collected offshore from the Fukushima Daiichi Nuclear Power Plant in a new paper published August 18, 2015, in the American Chemical Society's journal, Environmental Science and Technology. The research aids in understanding what happens to Fukushima contaminants after they are buried on the seafloor off coastal Japan. Led by Ken Buesseler, a senior scientist and marine chemist at the Woods Hole Oceanographic Institution (WHOI), the team found that a small fraction of contaminated ...

Just 1 in 10 are referred for cardiac rehab after treatment for heart failure

2015-08-18

Only 1 in 10 heart failure patients is referred to a cardiac rehabilitation program after being hospitalized, despite strong evidence that such exercise programs improve quality of life and reduce the likelihood of future hospitalizations. The findings, from a UCLA-led study, appear in the August 25 Journal of the American College of Cardiology. Researchers drew the data from a national database of more than 100,000 people with heart failure who were discharged from hospitals between 2005 and 2014 and were eligible for cardiac rehabilitation programs. "Although we expected ...

Breakthrough optics pave way for new class of intriguing technologies

2015-08-18

A new class of fascinating technologies -- including optics in computing, telecommunications links and switches, and virtually any other optical component -- could be created simply by configuring a mesh of light-controlling devices known as interferometers. This is similar to the way electronic semiconductors can fashion the wide array of digital technologies we have at our disposal today. Optical technologies have the potential to greatly reduce the power consumption of computers, speed telecommunications, and enhance the sensitivity of chemical and biological sensors. ...